FindMyKOL

Gregory Gressel, MD

Enriched profile

Clinical Associate Professor · Michigan State University College of Human Medicine

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Grand Rapids, MI · Midwest · United StatesSpecialtyGynecologic OncologyFocusEndometrial and Cervical Cancer Treatments+4
Active KOLFindMyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Gregory Gressel is Clinical Associate Professor at Michigan State University College of Human Medicine. OpenAlex indexes 88 publications with 677 citations (h-index 14).

Data verified 5 Nov 2026

Overview

Updated 7 Nov 2026

Gregory Gressel, MD, is Clinical Associate Professor at Michigan State University College of Human Medicine. The public record shows 88 publications with 677 citations (h-index 14), centered on Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Venous Thromboembolism Diagnosis and Management. It also documents industry payments reported by 11 companies.

  • Most recent indexed publication: 2025 · Journal of clinical oncology
  • Top research focus: Endometrial and Cervical Cancer Treatments
  • Open Payments reporting from 11 companies

Generated from the cited public record · current as of 7 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Ovarian / Gynecologic CancerNeuro-Oncology / GliomaAtrial FibrillationHead & Neck CancerCushing's SyndromeThyroid DisordersBreast CancerMultiple MyelomaLymphomaSubstance Use DisordersESRD / DialysisChronic Kidney DiseaseColorectal Cancer

Research focus

OpenAlex concept fingerprint
Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentVenous Thromboembolism Diagnosis and ManagementInnovations in Medical EducationUterine Myomas and Treatments

Drugs & molecules

across trials, industry payments and publications
Enhertugeneric · TrastuzumabClinical trials—Industry payments1Publications2Lenvimageneric · LenvatinibClinical trials—Industry payments33Publications—Zejulageneric · NiraparibClinical trials—Industry payments20Publications—Jemperligeneric · DostarlimabClinical trials—Industry payments10Publications—Elaheregeneric · Mirvetuximab soravtansineClinical trials—Industry payments8Publications—Tivdakgeneric · TisotumabClinical trials—Industry payments7Publications—Lynparzageneric · OlaparibClinical trials—Industry payments3Publications—Onglyzageneric · SaxagliptinClinical trials—Industry payments2Publications—Rubracageneric · RucaparibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eisai Inc.Clinical trials—Industry payments38GlaxoSmithKline, LLC.Clinical trials—Industry payments27AstraZeneca Pharmaceuticals LPClinical trials—Industry payments9Abbvie Inc.Clinical trials—Industry payments7Pfizer Inc.Clinical trials—Industry payments5Seagen Inc.Clinical trials—Industry payments3Baxter HealthcareClinical trials—Industry payments2Clovis Oncology, Inc.Clinical trials—Industry payments1ImmunoGen, Inc.Clinical trials—Industry payments1Myriad Genetic Laboratories, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
88publications

Publications indexed by OpenAlex, matched via ORCID. 4 in PubMed. Counts exclude supporting files.

677citations

Citations across these publications.

14h-index

H-index from these publications. i10-index 18.

Clinical & industry

trials, payments and federal funding
0clinical trials

Investigator role on registered studies.

View trials ↓
11companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Principal investigator

    MSU and Corewell Health 1M research project on the HTR3A serotonin receptor in high-grade endometrial cancer

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →innovationcenter.msu.edu ↗

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →

Industry payments

Updated 6 Nov 2026

11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 6 Nov 2026

8 congress contributions (2016–2024) across AACR, ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 6 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 6 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Nicole Suzanne Nevadunsky29Dennis Yi‐Shin Kuo16Nicole A. Vilardo11Sara S. Isani11Erika H. Banks10Shayan M. Dioun10Dennis Y.-S. Kuo9Alessandro Davide Santin8Elena Ratner8Gary L. Goldberg8Eirwen Murray Miller8Peter E. Schwartz7Akiva Pesach Novetsky6Gary H. Altwerger6Lauren Turker6Joan Tymon‐Rosario5Masoud Azodi5Anne Van Arsdale5K. E. George5Melissa J. Fazzari4Marina Frimer4Lisa R. Gabor4Lisbet S. Lundsberg3Divya Gowthaman3Gulden Menderes3Babak Litkouhi3Rachel Borczuk3Jennifer R. Jorgensen3Michael Richley3Kaitlin E. Haines3Ken Yu Lin3Nisha Bansal3Diana P. English3Xianhong Xie3Mark B. Woodland3Larissa Alejandra Meyer2Maya M. Hammoud2Willemien J. van Driel2Dee Sparacio2

Online presence

Updated 6 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/gregory-gressel-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    humanmedicine.msu.edu/news/2024-msu-corewell-mark-17-year-partnership.html

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →humanmedicine.msu.edu ↗
  • Other

    applykite.com/professors/gregory-gressel-536a77a4-60e9-4300-92fe-612d1154c1fa

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →applykite.com ↗
  • Other

    sgo.org/news/germline-and-somatic-testing-for-ovarian-cancer-an-sgo-clinical-practice-statement

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sgo.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 6 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Member

    Uterine Corpus Cancer Subcommittee, NRG Oncology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nrgoncology.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.